Page last updated: 2024-11-13

ss220

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

SS220: Insect Repellent [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID40579125
SCHEMBL ID21379073
MeSH IDM0484771

Synonyms (15)

Synonym
298207-27-9
(2s)-2-methylpiperidinyl(1s)-3-cyclohexene-1-carboxamide
ss-220
(2s)-2-methylpiperidinyl (1s)-3-cyclohexene-1-carboxamide
ss220
[(1s)-cyclohex-3-en-1-yl]-[(2s)-2-methylpiperidin-1-yl]methanone
SCHEMBL21379073
(1s)-3-cyclohexen-1-yl[(2s)-2-methyl-1-piperidinyl]methanone
DTXSID101186531
ss 220 (insect repellent)
a8mxe67mxb ,
methanone, (1s)-3-cyclohexen-1-yl((2s)-2-methyl-1-piperidinyl)-
piperidine, 1-((1s)-3-cyclohexen-1-ylcarbonyl)-2-methyl-, (2s)-
(1s)-3-cyclohexen-1-yl((2s)-2-methyl-1-piperidinyl)methanone
unii-a8mxe67mxb
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.21 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index76.60 (26.88)
Search Engine Supply Index2.02 (0.95)

This Compound (51.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (16.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]